Related references
Note: Only part of the references are listed.Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study
Pierre-Olivier Blotiere et al.
BMJ OPEN (2020)
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
Torbjorn Tomson et al.
LANCET NEUROLOGY (2018)
Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Alastair Macfarlane et al.
BMC PREGNANCY AND CHILDBIRTH (2018)
A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age
Carol Paton et al.
BMJ OPEN (2018)
Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis
Marie Westwood et al.
HEALTH TECHNOLOGY ASSESSMENT (2018)
Retinoids and pregnancy: an update
Hannah Browne et al.
OBSTETRICIAN & GYNAECOLOGIST (2014)
Major congenital malformations after first-trimester exposure to ACE inhibitors
William O. Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
